Transplant Outcomes in Acute Leukemia (I)

Seminars in Hematology

Volumn 47, Issue 1, 2010, Pages 46-50

  Eapen, Mary ^a   Wagner, John E ^b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b Department of Pediatrics and the Blood   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LEUKEMIA; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER RECURRENCE; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE FREE SURVIVAL; DONOR SELECTION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; MORTALITY; PRIORITY JOURNAL; RECURRENCE RISK; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; BLOOD DONORS; CHILD; CORD BLOOD STEM CELL TRANSPLANTATION; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HUMANS; LEUKEMIA; PATIENT SELECTION; RECURRENCE; TIME FACTORS; TREATMENT OUTCOME;

EID: 72449180020     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminhematol.2009.10.007     Document Type: Article

References (18)

1. Lee S.J., Klein J., Haagenson M., Baxter-Lowe L., Confer D.L., Eapen M., et al. High resolution donor-recipient HLA matching contributes to the success of unrelated donor transplantation. Blood 110 (2007) 4576-4583
2. Woolfrey A., Klein J., Haagenson M., Spellman S.R., Battiwalla M., Gajewski J., et al. Evaluation of human leukocyte antigen matching requirements for unrelated donor peripheral blood stem cell transplant [abstract]. ASH Annual Meeting Abstracts 112 (2008) 563
3. Rocha V., Cornish J., Sievers E.L., Filipovich A., Locatelli F., Peters C., et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 97 (2001) 2962-2971
4. Eapen M., Rubinstein P., Zhang M.-J., Stevens C., Kutrzburg J., Scaradavou A., et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukemia: a comparison study. Lancet 369 (2007) 1947-1954
5. Wagner J.E., Barker J.N., DeFor T.E., Baker K.S., Blazar B.R., Eide C., et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and non-malignant diseases: influence of CD34 cell dose and HLA disaprity on treatment-related mortality and survival. Blood 100 (2002) 1611-1618
6. van Heeckeren W.J., Fanning L.R., Meyerson H.J., Fu P., Lazarus H.M., Cooper B.W., et al. Influence of human leukocyte antigen disparity and graft lymphocytes on allogeneic engraftment and survival after umbilical cord blood transplant in adults. B J Haematol 139 (2007) 464-474
7. Laughlin M.J., Eapen M., Rubinstein P., Wagner J.E., Zhang M.-J., Champlin R.E., et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 351 (2004) 2265-2275
8. Rocha V., Labopin M., Sanz G., Arcese W., Schwerdtfeger R., Bosi A., et al. Transplantation of umbilical cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med 351 (2004) 2276-2285
9. Gluckman E., and Rocha V. Donor selection for unrelated cord blood transplants. Curr Opin Immunol 18 (2006) 565-570
10. Atsuta Y., Suzuki R., Nagamura-Inoue T., Taniguchi S., Takahashi S., Kai S., et al. Disease specific analysis of unrelated cord blood transplantation compared with unrelated bone marrow transplantation in adult patients with acute leukemia. Blood 113 (2009) 1631-1637
11. Oh H., Loberiza F.R., Zhang M.-J., Ringden O., Akiyama H., Asai T., et al. Comparison of graft-versus-host disease and survival after HLA-identical sibling bone marrow transplantation in ethnic populations. Blood 105 (2005) 1408-1416
12. Barker J.N., Wesidorf D.J., DeFor T.E., Blazar B.R., McGlave P.B., Miller J.S., et al. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftmnet in adults with hematological malignancy. Blood 105 (2005) 1343-1347
13. Brunstein C.G., Barker J.N., Wesidorf D.W., DeForr T.E., Miller J.S., Blazar B., et al. Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease. Blood 110 (2007) 3064-3070
14. Robinson S.N., Ng J., Niu T., Yang H., McMannia J.D., Karandish S., et al. Superior ex-vivo cord blood expansion following co-culture with bone marrow derived mesenchymal stem cells. Bone Marrow Transplant 37 (2006) 359-366
15. Bautista G., Cabrera J.R., Regidor C., Fores R., Gracia-Marco J.A., Ojeda E., et al. Cord blood transplants supported by co-infusion of mobilized hematopoietic stem cells from a third party donor. Bone Marrow Transplant 43 (2009) 365-373
16. Jaroscak J., Goltry K., Smith A., Walters-Pick B., Martin P.L., Driscoll T.A., et al. Augmentation of umbilical cord blood (UCB) transplantation with ex-vivo expanded UCB cells: results of a phase I trial using the Asstrom Replicell System. Blood 101 (2003) 5061-5067
17. Eapen M., Logan B.R., Confer D.L., Haagenson M., Wagner J.E., Weisdorf D.J., et al. Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survival. Biol Blood Marrow Transplant 13 (2007) 1461-1468
18. Schmitz N., Eapen M., Horowitz M.M., Zhang M.-J., Klein J.P., Rizzo J.D., et al. Long-term outcome of patients transplanted with mobilized blood or bone marrow: a report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation. Blood 108 (2006) 4288-4290